NO20065030L - Aerosolformulering for inhalering av beta agonister. - Google Patents
Aerosolformulering for inhalering av beta agonister.Info
- Publication number
- NO20065030L NO20065030L NO20065030A NO20065030A NO20065030L NO 20065030 L NO20065030 L NO 20065030L NO 20065030 A NO20065030 A NO 20065030A NO 20065030 A NO20065030 A NO 20065030A NO 20065030 L NO20065030 L NO 20065030L
- Authority
- NO
- Norway
- Prior art keywords
- inhalation
- aerosol formulation
- beta agonists
- agonists
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Det beskrives en drivgassfri aerosolformulering som inneholder én eller flere forbindelser med den generelle formel (1), hvor restene R', R2 , R3 og X- kan ha de betydninger som er angitt i kravene og i beskrivelsen, for inhalasjon.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004024452A DE102004024452A1 (de) | 2004-05-14 | 2004-05-14 | Aerosolformulierung für die Inhalation von Betaagonisten |
PCT/EP2005/005028 WO2005110421A2 (de) | 2004-05-14 | 2005-05-10 | Aerosolformulierung für die inhalation von betaagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065030L true NO20065030L (no) | 2006-11-30 |
Family
ID=34979667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065030A NO20065030L (no) | 2004-05-14 | 2006-11-02 | Aerosolformulering for inhalering av beta agonister. |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1809293B1 (no) |
JP (1) | JP4620730B2 (no) |
KR (1) | KR101288791B1 (no) |
CN (1) | CN101056640A (no) |
AR (1) | AR049096A1 (no) |
AU (1) | AU2005244414B2 (no) |
BR (1) | BRPI0511135B8 (no) |
CA (1) | CA2564379C (no) |
DE (1) | DE102004024452A1 (no) |
DK (1) | DK1809293T3 (no) |
EA (1) | EA012583B1 (no) |
EC (1) | ECSP067004A (no) |
ES (1) | ES2575925T3 (no) |
HU (1) | HUE027780T2 (no) |
IL (1) | IL179218A (no) |
MX (1) | MXPA06013216A (no) |
MY (1) | MY148403A (no) |
NO (1) | NO20065030L (no) |
PE (1) | PE20060311A1 (no) |
PL (1) | PL1809293T3 (no) |
SG (1) | SG152265A1 (no) |
TW (1) | TWI356703B (no) |
UA (1) | UA87312C2 (no) |
UY (1) | UY28891A1 (no) |
WO (1) | WO2005110421A2 (no) |
ZA (1) | ZA200607462B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
AU2006281449B2 (en) | 2005-08-15 | 2013-01-31 | Boehringer Ingelheim International Gmbh | Method for producing betamimetics |
KR20080067699A (ko) * | 2005-11-09 | 2008-07-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 흡입용 에어로졸 제형 |
UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
US20110319402A1 (en) * | 2008-11-21 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
CA2738617A1 (en) * | 2008-11-21 | 2011-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
WO2014056840A1 (en) | 2012-10-09 | 2014-04-17 | Boehringer Ingelheim International Gmbh | Beta-2-adrenoceptor agonist for the treatment of cough |
CN110062625A (zh) | 2016-12-12 | 2019-07-26 | 勃林格殷格翰国际有限公司 | 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
JPH0637388B2 (ja) * | 1986-02-17 | 1994-05-18 | 千寿製薬株式会社 | 水性液剤 |
GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
ES2523518T3 (es) * | 2004-04-22 | 2014-11-26 | Boehringer Ingelheim International Gmbh | Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias |
DE102004019539A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
DE102004024451A1 (de) * | 2004-05-14 | 2005-12-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten |
DE102004024454A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
-
2004
- 2004-05-14 DE DE102004024452A patent/DE102004024452A1/de not_active Withdrawn
-
2005
- 2005-05-10 AU AU2005244414A patent/AU2005244414B2/en active Active
- 2005-05-10 JP JP2007512068A patent/JP4620730B2/ja active Active
- 2005-05-10 PL PL05747843.0T patent/PL1809293T3/pl unknown
- 2005-05-10 DK DK05747843.0T patent/DK1809293T3/en active
- 2005-05-10 SG SG200902777-2A patent/SG152265A1/en unknown
- 2005-05-10 MX MXPA06013216A patent/MXPA06013216A/es active IP Right Grant
- 2005-05-10 ES ES05747843.0T patent/ES2575925T3/es active Active
- 2005-05-10 KR KR1020067026225A patent/KR101288791B1/ko active IP Right Grant
- 2005-05-10 CA CA2564379A patent/CA2564379C/en active Active
- 2005-05-10 BR BRPI0511135A patent/BRPI0511135B8/pt active IP Right Grant
- 2005-05-10 UA UAA200612949A patent/UA87312C2/ru unknown
- 2005-05-10 CN CNA2005800154865A patent/CN101056640A/zh active Pending
- 2005-05-10 WO PCT/EP2005/005028 patent/WO2005110421A2/de active Application Filing
- 2005-05-10 EP EP05747843.0A patent/EP1809293B1/de active Active
- 2005-05-10 EA EA200602017A patent/EA012583B1/ru not_active IP Right Cessation
- 2005-05-10 HU HUE05747843A patent/HUE027780T2/en unknown
- 2005-05-11 UY UY28891A patent/UY28891A1/es not_active Application Discontinuation
- 2005-05-12 PE PE2005000529A patent/PE20060311A1/es not_active Application Discontinuation
- 2005-05-12 MY MYPI20052158A patent/MY148403A/en unknown
- 2005-05-13 TW TW094115491A patent/TWI356703B/zh not_active IP Right Cessation
- 2005-05-13 AR ARP050101959A patent/AR049096A1/es unknown
-
2006
- 2006-09-06 ZA ZA200607462A patent/ZA200607462B/en unknown
- 2006-11-02 NO NO20065030A patent/NO20065030L/no not_active Application Discontinuation
- 2006-11-13 EC EC2006007004A patent/ECSP067004A/es unknown
- 2006-11-13 IL IL179218A patent/IL179218A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065030L (no) | Aerosolformulering for inhalering av beta agonister. | |
NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
NO20090407L (no) | Aerosolformulering for inhalering av beta agonister | |
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
NO20090410L (no) | Aerosolformuleringer for inhalaering av beta-agonister | |
NO20050828L (no) | lndol-3-svovelderivater | |
ATE301653T1 (de) | Pyrazolopyridine | |
ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
MY163503A (en) | Aerosol formulations for the inhalation of beta agonists | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
NO20034011L (no) | Steroider som agonister for FXR | |
TR200302242T2 (tr) | Protein kinaz önleyicileri olarak pirolopirimidinler | |
NO20070555L (no) | Kinazolinonderivater som parp-inhibitorer | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20065060L (no) | Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser | |
NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
WO2004100865A3 (en) | New benzimidazole derivatives | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
NO20040881L (no) | Orale antidiabetes midler. | |
NO20072089L (no) | Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav | |
NO20081587L (no) | Aerosolformulering for inhalering | |
NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
ATE274515T1 (de) | Pyrazolopyridinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |